Acute Respiratory Distress In COVID-19 Patients May Be Helped By Arthritis Med

Video Credit: Wochit Entertainment
Published on May 8, 2020 - Duration: 00:34s

Acute Respiratory Distress In COVID-19 Patients May Be Helped By Arthritis Med

A new study reveals a drug meant to treat rheumatoid arthritis may be of help to patients struggling to breathe due to the novel coronavirus.

According to UPI, Anakinra has been used off-label to treat patients who developed acute respiratory distress syndrome caused by COVID-19.

ARDS is the main cause of death from COVID-19.

The drug is the latest prescription medication developed for another purpose to be evaluated for use in treating COVID-19.


You are here

Related videos from verified sources

Study Reveals The Toll On Mental Health Pandemic Took On Italian Healthcare Workers 00:36
Video credit: Wochit Tech - Published on May 28, 2020 

Study: As COVID-19 Progresses, 40% May Not Show Any Symptoms At All 00:41
Video credit: Wochit Business - Published on May 27, 2020 

Large Scale UK Study Highlights Major Risk Factors In Dying From COVID-19 00:34
Video credit: Wochit Tech - Published on May 23, 2020 

You might like